Boston type I keratoprosthesis-donor cornea interface evaluated by high-definition spectral-domain anterior segment optical coherence tomography

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 1355-1359

  Alzaga Fernandez, Ana G ^a   Radcliffe, Nathan M ^a   Sippel, Kimberly C ^a   Rosenblatt, Mark I ^a   Sood, Priyanka ^a   Starr, Christopher E ^a   Ciralsky, Jessica B ^a   D'Amico, Donald J ^a   Kiss, Szilárd ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Anterior segment optical coherence tomography; Epithelialization; Keratoprosthesis

Indexed keywords

ANTERIOR EYE SEGMENT; APHAKIA; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CORNEA TRANSPLANTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; KERATOPATHY; KERATOPROSTHESIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;

EID: 84865807992     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S34787     Document Type: Article

References (27)

1. Ament JD, Todani A, Pineda R, et al. Global corneal blindness and the Boston keratoprosthesis type 1. Am J Ophthalmol. 2010;149(4): 537-539.
2. Colby KA, Koo EB. Expanding indications for the Boston keratoprosthesis. Curr Opin Ophthalmol. 2011;22(4):267-273.
3. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. April 17, 2012. [Epub ahead of print.]
4. Traish AS, Chodosh J. Expanding application of the Boston type 1 keratoprosthesis due to advances in design and improved postoperative therapeutic strategies. Semin Ophthalmol. 2010;25(5-6):239-243.
5. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15(2):179-184.
6. Aquavella JV, Qian Y, McCormick GJ, Palakuru JR. Keratoprosthesis: the Dohlman-Doane device. Am J Ophthalmol. 2005;140(6):1032-1038.
7. Harissi-Dagher M, Khan BF, Schaumberg DA, Dohlman CH. Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis. Cornea. 2007;26(5):564-568.
8. Klufas MA, Colby KA. The Boston keratoprosthesis. Int Ophthalmol Clin. 2010;50(3):161-175.
9. Khan BF, Harissi-Dagher M, Khan DM, Dohlman CH. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47(2):61-71.
10. Nouri M, Terada H, Alfonso EC, Foster CS, Durand ML, Dohlman CH. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119(4):484-489.
11. Ayres BD. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea. 2012;31(7):846.
12. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eye with Boston keratoprosthesis. Cornea. 2009;28(8):896-901.
13. Chew H, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28(9):989-996.
14. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology. 2006;113(10): 1779-1784.
15. Jain V, Mhatre K, Shome D, Pineda R. Fungal keratitis with the type 1 Boston keratoprosthesis: early Indian experience. Cornea. 2012;31(7): 841-843.
16. Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol. 2012; 96(6):776-780.
17. Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea. 2012;31(4):346-349.
18. Ramchandran RS, Diloreto DA Jr, Chung MM, et al. Infectious endophthamitis in adult eyes receiving Boston type 1 keratoprosthesis. Ophthalmology. 2012;119(4):674-681.
19. Yu JF, Huang YF. Characteristics of endophthalmitis with Boston keratoprosthesis. Cornea. 2012;31(5):594.
20. Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology. 2011;118(8):1543-1550.
21. Utine CA, Tzu JH, Akpek EK. Clinical features and prognosis of Boston type 1 keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm. 2011;19(6):413-418.
22. Kiang L, Rosenblatt MI, Sartaj R, et al. Surface epithelium of the type I Boston keratoprosthesis front plate: immunohistochemical and high-definition optical coherence tomography characterization. Graefes Arch Clin Exp Ophthalmol. 2012 Aug;250(8):1195-9.
23. Khalifa YM, Davis D, Mamalis N, Moshirfar M. Epithelial growth over the optic surface of the type 1 Boston keratoprosthesis: histopathology and implications for biointegration. Clin Ophthalmol. 2010;4: 1069-1071.
24. Garcia JP Jr, De la Cruz J, Rosen RB, Buxton DF. Imaging implanted keratoprosthesis with anterior-segment optical coherence tomography and ultrasound biomicroscopy. Cornea. 2008;27(2):180-188.
25. Garcia JP Jr, Ritterband DC, Buxton DF, De la Cruz J. Evaluation of the stability of Boston Type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography. Cornea. 2010;29(9): 1031-1035.
26. Dohlman CH, Dudenhoefer EJ, Khan BF, Morneault S. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28(2):72-74.
27. Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin. 2008;48(2):43-51.